Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Cellular Signalling (2020) Vol. 78, pp. 109871-109871
Closed Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

siRNA: Mechanism of action, challenges, and therapeutic approaches
Walhan Alshaer, Hadil Zureigat, Arwa Al Karaki, et al.
European Journal of Pharmacology (2021) Vol. 905, pp. 174178-174178
Closed Access | Times Cited: 270
Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy
Paul B. Tchounwou, Shaloam Dasari, Felicite K. Noubissi, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 303-328
Open Access | Times Cited: 267
Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
Asal Jalal Abadi, Sepideh Mirzaei, Mahmood Khaksary Mahabady, et al.
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 189-213
Closed Access | Times Cited: 148
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 147
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 136
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112963-112963
Open Access | Times Cited: 80
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114204-114204
Open Access | Times Cited: 72
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
Mehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106568-106568
Open Access | Times Cited: 69
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 100
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 95
Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Asal Jalal Abadi, Ali Zarrabi, Mohammad Gholami, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 304-304
Open Access | Times Cited: 62
The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review
Bahareh Farasati Far, Kimia Vakili, Mobina Fathi, et al.
Life Sciences (2022) Vol. 316, pp. 121340-121340
Closed Access | Times Cited: 60
Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells
Mu Qi, Masoud Najafi
International Immunopharmacology (2021) Vol. 98, pp. 107895-107895
Closed Access | Times Cited: 57
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy
Yu Chong, Bo Yang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 129, Iss. 6, pp. 397-415
Open Access | Times Cited: 57
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 53
Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases
Yonghui Lv, Meiying Wu, Zhe Wang, et al.
Cell Biology and Toxicology (2022) Vol. 39, Iss. 3, pp. 827-851
Closed Access | Times Cited: 47
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 35
Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma
Gao Shan, Minchao Kang, Wang Jizhao, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 229, pp. 115346-115346
Closed Access | Times Cited: 31
Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers
Maliheh Entezari, Ghazaleh Gholamiyan Yousef Abad, Behnaz Sedghi, et al.
Environmental Research (2023) Vol. 225, pp. 115673-115673
Closed Access | Times Cited: 23
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 22
The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective
Samaneh Kahkesh, Seyedeh Mahdieh Khoshnazar, Yasaman Gholinezhad, et al.
Pathology - Research and Practice (2024) Vol. 257, pp. 155316-155316
Closed Access | Times Cited: 12
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
Milad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Life Sciences (2021) Vol. 278, pp. 119649-119649
Closed Access | Times Cited: 54
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Courtney Clark, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 3, pp. 166326-166326
Open Access | Times Cited: 53
Interplay between SOX9 transcription factor and microRNAs in cancer
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
International Journal of Biological Macromolecules (2021) Vol. 183, pp. 681-694
Closed Access | Times Cited: 47
Page 1 - Next Page

Scroll to top